IL17A and myeloid sarcoma: Given the capability of CD6 to bind to bacteria/LPS [45], and the evidence for a role of IL-17A in mediating protection against various pathogens [47], [48], this may be of relevance to the concept of infectious agents acting as triggers for MS.